A RANDOMIZED, MULTICENTER, OPEN-LABEL CROSS-OVER STUDY TO EVALUATE PATIENT PREFERENCE AND SATISFACTION OF SUBCUTANEOUS ADMINISTRATION OF THE FIXED-DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB IN PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER
2022-06-29
عنوان الدراسة
A RANDOMIZED, MULTICENTER, OPEN-LABEL CROSS-OVER STUDY TO EVALUATE PATIENT PREFERENCE AND SATISFACTION OF SUBCUTANEOUS ADMINISTRATION OF THE FIXED-DOSE COMBINATION OF PERTUZUMAB AND TRASTUZUMAB IN PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER
داعم الدراسة
Roche
دواء الدراسة
Trastuzumab & Pertuzumab
رقم بروتوكول الدراسة
MO40628
حالة الدراسة
Completed
موقع الدراسة
KFSH & KFMC
مرحلة الدراسة
2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。